2012 Movember Clinician Scientist Awards











Prostate Cancer Canada would like to recognize the Movember Foundation as a key funder of this program.

Prostate Cancer Canada is pleased to announce the awarding of two Movember Clinician Scientist Awards.

In order to decide which research projects should receive funding, each application is thoroughly reviewed by at least two cancer experts. These experts make recommendations to PCC regarding which research projects to fund. This process is called 'peer review'. The peer review process ensures that only the most meritorious research is supported. This year's successful research projects explore many different areas of prostate cancer including novel treatment therapies and the development of new tools to help better predict disease progression.


Movember Clinician Scientist Awards

Investigator Host Institution Project Title Total Award  Award Period        
Peter Black University of British Columbia Circulating tumour cells in prostate cancer: the metastatic window $300,000  July 1, 2012- June 30, 2014
Girish Kulkarni Princess Margaret Hospital        Biopsy avoidance in patients at risk for prostate cancer and in patients with low risk prostate cancer: developing tools for personalized medicine $300,000 July 1, 2012 -
June 30, 2014

 





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More

Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More


Click here for news archive